Integrated Program in Neuroscience - Block 3

The Info-Neuro cart schedule for July is now available!

��VR��Ƶ — Tue, 30 Jun 2026 14:49:31 +0000

The Info-Neuro resources cart schedule for July is as follows:

National Indigenous Peoples Day

��VR��Ƶ — Sun, 21 Jun 2026 04:01:23 +0000

Today is National Indigenous Peoples Day—a time to recognize and celebrate the traditions, cultures, and contributions of First Nations, Inuit and Métis.

We encourage you to take some time to learn more about First Nations, Inuit and Métis as well as our collective past. The best way to do this is through their own voices. We’ve selected books by Indigenous authors from our book collection on Indigenous health.

Stop by in person at Room 354 (3rd floor) at the Neuro (Montreal Neurological Institute-Hospital) to borrow our physical books.

Pride Month Reading List

��VR��Ƶ — Wed, 17 Jun 2026 20:01:36 +0000

Celebrate Pride Month with MUHC Libraries and Patient Resource Centers!

In honour of Pride Month, MUHC libraries and patient resource centers are highlighting their resources on 2SLGBTQI+ health and wellness.

If you would like to explore topics such as identity, family life, relationships and mental health, you are sure to find something of interest!

June is ALS Awareness Month

��VR��Ƶ — Mon, 08 Jun 2026 14:33:43 +0000

“Letters to ALS: Our Journeys to Hope” is a new book that brings together inspiring and touching stories from people living with ALS, their loved ones, healthcare professionals, and researchers, including members of The Neuro community.

You can pick up a free copy of the book in person at the Neuro Patient Resource Centre, located on the 3rd floor, Room 354.

The Neuro's Virtual Integrated Patient Platform receives major funding

��VR��Ƶ — Thu, 04 Jun 2026 17:14:59 +0000

Brain Canada support will help accelerate the discovery of new treatments for brain and nervous system disorders

An innovative project led by Dr. Guy Rouleau at The Neuro has received major funding from Brain Canada, one of four platforms that are advancing treatment discovery across a wide range of neurological disorders. In total the four platforms are being supported with a $8,926,500 investment.

Blood proteins flag multiple sclerosis years before diagnosis, opening a window for prevention

��VR��Ƶ — Tue, 26 May 2026 14:12:51 +0000

Of more than 2,500 blood proteins screened, a small group may drive MS and signal who will develop it

A new study has revealed a group of blood proteins that are altered in people who go on to develop multiple sclerosis (MS), in some cases more than a decade before diagnosis. The findings offer hope that a simple blood test could one day identify people at high risk of MS in time to act before damage occurs.

Neuro researchers lead projects awarded $14.5 million

��VR��Ƶ — Wed, 18 Mar 2026 13:31:29 +0000

Funds will help acquire and develop cutting-edge infrastructure to advance research capacity

Five researchers from The Neuro (Montreal Neurological Institute-Hospital) are leading innovative new projects that have received major funding from Canada Foundation for Innovation’s Innovation Fund. They will be funded for a total of $14.5 million, part of $42 million going to ��VR��Ƶ scientists.

Leading through change: Three Canadian university leaders reflect on implications of gen AI for higher ed

��VR��Ƶ — Wed, 11 Mar 2026 19:22:18 +0000

We recently had the opportunity to ask senior leaders from three of Canada’s top universities a big question: “How is generative AI reshaping higher education?”

Findings of ��VR��Ƶ study could lead to new longevity therapies and improved fall prevention

��VR��Ƶ — Mon, 23 Feb 2026 14:46:40 +0000

A new ��VR��Ƶ study has found a direct link between age‑related declines in neuron activity in the cerebellum and worsening motor skills, including gait, balance and agility. While it is well known that these abilities diminish with age, this is the first research to pinpoint how changes in Purkinje cells – a key type of cerebellar neuron – drive this decline and translate into measurable changes in behaviour and physical function.

RNA therapy may be a solution for infant hydrocephalus

��VR��Ƶ — Thu, 29 Jan 2026 16:57:57 +0000

For the first time, drug targeting genetic mutation shown to have positive impact in mice models

Hydrocephalus is a life-threatening condition that occurs in about 1 in 1,000 newborns and is often treated with invasive surgery. Now, a new study offers hope of preventing hydrocephalus before it even occurs.